CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PharmaTimes
Original article

Laverock unveils new in vivo programmes in oncology

Positive
AI Analysis

Summary

Laverock unveiled new in vivo programmes in oncology, expanding its pipeline into CAR-T and genetic medicine areas.

Importance:3/10
Sentiment:
0.30
pipeline expansiononcologyCAR-Tgenetic medicinein vivo programmes
Related Companies

Read the original article

Published by PharmaTimes on October 8, 2026 11:23 AM

Read Original